Clinical Trial Update: Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating varenicline for smoking cessation in schizophrenia with antipsychotic-induced neurological symptoms as correlates; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinsonism
• Schizoaffective Disorder
• Schizophrenia
• Tardive Dyskinesia
• Tobacco Smoking

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Corporal Michael J. Crescenz VA Medical Center | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: RECRUITING